ARTICLE | Company News
Pepscan Therapeutics, J&J deal
September 27, 2010 7:00 AM UTC
Pepscan will use its Chemical LInkage of Peptides onto Scaffolds (CLIPS) technology to develop a peptide against an undisclosed target from Johnson & Johnson's Tibotec Pharmaceuticals Ltd. unit. CLIPS...